Of the 14,611 participants aged 12 years or older who were enrolled in the NHANES 2003–2004 and 2005–2006 cycles, 7967 had complete interview and physical examination data and were therefore eligible for this study (
Table 1). The mean age of study participants at baseline was 44.5 years. Most participants were Caucasian (73.4%), were female, (51.1%), and had some college education (53.3%). Prevalent comorbidities in the study population with complete data included obesity (30.1%; confidence interval [CI], 28.0–32.2), arthritis (25.9%; 95% CI, 24.2–27.6), COPD/asthma (10.5%; 95% CI, 9.5–11.7), and diabetes mellitus (7%; 95% CI, 6.1–8.1).
Compared to NHANES participants without complete interview and physical examination data, our study population was older, more likely to be male, more likely to be non-Hispanic white, and more likely to have some college education (P < 0.01). Our study population was significantly less likely to report a history of stroke and arthritis (P < 0.01 for both). No significant differences were reported between the groups for obesity, diabetes mellites, CHF, COPD and asthma.
Of 7967 study participants, 7758 had functionally binocular vision and 172 were functionally monocular. Demographic characteristics of binocular and functionally monocular groups were compared (
Table 2). In functionally binocular participants, corrected visual acuity (VA) of the better-seeing eye was 20/20 (95% CI, 20/20, 20/25) compared to 20/30 (95% CI, 20/25, 20/40) in functionally monocular participants (
P < 0.01). All functionally monocular participants had a visual acuity of 20/80 or better in the better seeing eye. The median log of minimum angle of resolution (logMAR) difference between better- and worse-eye visual acuity was 0.7 (interquartile range, 0.4–0.8). Compared to binocularly sighted participants, functionally monocular participants were older, had worse vision in their sighted eye, and were less likely to have attended college. They were significantly more likely to be obese and to report a history of diabetes mellites, stroke, CHF, arthritis, and COPD or asthma (
P < 0.01 for all). There were no significant differences in gender or race/ethnicity across visual acuity status.
On average, functionally monocular participants took fewer steps per day (7020 vs. 10,042,
P < 0.01) and engaged in fewer minutes of MVPA (13.7 vs. 27.0,
P < 0.01) per day compared to binocularly sighted participants. Parsed differently, 60.6% (95% CI, 52.1–68.4) of monocular participants met the American Heart Association (AHA) published goal of 10,000 steps per day compared to 73.1% (95% CI, 70.5–75.4) of binocularly sighted participants (
P < 0.01). When adjusted for age only, functionally monocular participants took fewer steps per day (9277 with 95% CI, 8800–9753 vs. 10,057 with 95% CI, 9,832–10,281) and engaged in similar minutes of MVPA (26.75 with 95% CI, 22.0–31.5; 26.7 with 95% CI, 25.6–27.7) (
Fig. 1).
Multivariable negative binomial regression models adjusting for age, better-eye visual acuity, gender, educational attainment, and health variables were built. These variables were selected based on their relationship to physical activity in univariable models and differences between vision groups. Monocular vision was associated with a 26% decrease in daily time spent in MVPA (95% CI, 16%–41) and a 16% decrease in daily steps (95% CI, 5%–26%) (
Table 4). Poorer better-eye visual acuity was also strongly associated with reduced physical activity: 0.1 logMAR units worse, equivalent to one line worse on the logMAR eye chart, was associated with a 5.5% decrease in MVPA (95% CI, 3.3%–6.9%) and a 5.2% decrease in daily steps per day (95% CI, 4.0%–6.2%). Older age, female gender, obesity, CHF, and arthritis were also associated with a statistically significant decrease in PA in both models (
Table 3).
Exploratory analysis was also performed for balance and fall history. Balance questionnaire data were available for 2006 of 6644 (30%) participants, and balance examination results were available for 1930 of 6644 (29%). Twenty-three of 76 (30%) functionally monocular participants and 492 of 1930 (25%) functionally binocular participants reported difficulty with dizziness, balance, or falls within the past year (age-adjusted P = 0.58). Differences of self-reported dizziness, balance, and falls between functionally monocular and binocular groups were also not statistically significant. When asked if their dizziness or balance problem was related to any items on a list of health variables, 2 of 23 (9%) functionally monocular and 32 of 485 (7%) functionally binocular participants selected “vision or seeing problems” (age-adjusted P = 0.8). Forty-five of 68 (66%) functionally monocular participants failed the modified Romberg test of balance, compared to 835 of 1732 (48%) functionally binocular participants (age- adjusted P = 0.5).
An additional exploratory analysis divided the functionally monocular group into persons with near-normal visual acuity in their seeing eye (vision 20/40 or better, n = 115) and those with more impaired visual acuity (vision between 20/200 and 20/40 in the better-seeing eye, n = 57). Both groups took fewer steps than binocularly sighted patients: in analyses adjusted for age only, monocular persons with near-normal vision in their better-seeing eye took 17% fewer steps (95% CI, 8–26%; P < 0.01) and those with reduced vision in their better-seeing eye took 40% fewer steps (95% CI, 25–52%; P < 0.01). In analyses adjusted for age, gender, education, and comorbidities, monocular persons with near-normal vision in their better-seeing eye took 18% fewer steps (95% CI, 4–28%; P = 0.02) and those with reduced vision in their better-seeing eye took 34% fewer steps (95% CI, 19–47%; P < 0.01). Monocular persons with impaired vision in their better-seeing eye engaged in less MVPA compared to those with binocular vision, whereas those with near-normal vision in their better-seeing eye engaged in similar amounts: in analyses adjusted for age only, monocular persons with near-normal vision in their better-seeing eye took 19% fewer steps (95% CI, −8% to 40%; P < 0.15), and those with reduced vision in their better-seeing eye took 62% fewer steps (95% CI, 47%–77%; P < 0.01). In analyses adjusted for age, gender, education, and comorbidities, monocular persons with near-normal vision in their better-seeing eye took 33% fewer steps (95% CI, −2% to 42%; P = 0.07) and those with reduced vision in their better-seeing eye took 56% fewer steps (95% CI, 40%–68%; P < 0.01).